MedTrace Logo

Clinical Assessment of Barley and Oat Phytochemicals

NCT01303562 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2013-05-27

No results posted yet for this study

Summary

The goal of this placebo-controlled, 3-way crossover study is to determine the acute (24-h) bioavailability and pharmacokinetics of the major phytochemicals found whole barley and oats, as well as their effects on selected measures of antioxidation, inflammation, insulin sensitivity/glucose regulation, and vascular remodeling following challenge by an oral glucose tolerance test (OGTT).

Conditions

  • Healthy

Interventions

OTHER

Whole grain oats and barley

One time dose of 48 g whole grain flour in 2 small muffins (24 g flour per muffin) per intervention

Sponsors & Collaborators

  • Kellogg Company

    collaborator INDUSTRY

  • Tufts University

    lead OTHER

Principal Investigators

  • Jeffrey B Blumberg, PhD · Tufts Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-04-30
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01303562 on ClinicalTrials.gov